Reader Comments
Post a new comment on this article
Post Your Discussion Comment
Please follow our guidelines for comments and review our competing interests policy. Comments that do not conform to our guidelines will be promptly removed and the user account disabled. The following must be avoided:
- Remarks that could be interpreted as allegations of misconduct
- Unsupported assertions or statements
- Inflammatory or insulting language
Thank You!
Thank you for taking the time to flag this posting; we review flagged postings on a regular basis.
closeMedia Coverage of this Article
Posted by PLOS_ONE_Group on 04 Jan 2013 at 22:15 GMT
The following article represents some of the media coverage that has occurred for this paper:
Publication: PR Newswire
Title: “Revalesio's RNS60 Protects Myelin and Halts Multiple Sclerosis in Mice -- TACOMA, Wash., Jan. 3, 2013 /PRNewswire/ --”
http://www.prnewswire.com...
If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.
RE: Media Coverage of this Article
PLOS_ONE_Group replied to PLOS_ONE_Group on 18 Jan 2013 at 23:21 GMT
The following article represents some of the media coverage that has occurred for this paper:
Publication: Multiple Sclerosis Research Blog
Title: “Multiple Sclerosis Research: Research: Is a salt tablet going to treat MS make way for super saline”
http://multiple-sclerosis...
If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.
RE: Media Coverage of this Article
PLOS_ONE_Group replied to PLOS_ONE_Group on 15 Nov 2013 at 22:26 GMT
The following article represents some of the media coverage that has occurred for this paper:
Publication: PR Newswire
Title: “Revalesio Initiates Phase IIa Study of RNS60 in Multiple Sclerosis at University... -- TACOMA, Wash., Nov. 11, 2013 /PRNewswire/ --”
http://www.prnewswire.com...
If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.